Treon Verdery
unread,Oct 15, 2022, 8:07:33 AM10/15/22You do not have permission to delete messages in this group
Either email addresses are anonymous for this group or you need the view member email addresses permission to view the original message
to
The difference between the electrophoresisized proteins between the two could be noted and the physiochemicals more prevalent at the long lived tardigrades could be tested on yeast and c elegans for longevity effects, then tested on mice and primates, similarly the shorter lived tardigrades could have a surplus of deleterious chemicals and if those modulate yeast and c elegans longevity then they could be tested at mice, with some amount of the mice being given antibodies to those chemicals to find out if they live longer, that could then become a human longevity technology
NaPCA, which as dry powder pulls water out of the air to make a puddle could be made a part of transdermal patches, it is possible this hyperhydrates the skin causing greater drug absorption, it is however also possible that this causes the drug to travel to the NaPCA
Alginate gel transdermal patches, it is possible a puffy transdermal drug patch with a blob of alginate gel could have enzymes at it that disintegrate the gel causing s blob of water or water and solvent or harmless surfactant on the dermis causing greater transport of the drug, enzymatically degradable NaPCA could start out as a flat dry decal, puff up with water from the dermis, the NaPCA enzymatically disintegrates causing a bubble of water, solvents, and surfactants on the skin under the decal